Skip to content

Free cash flow at other companies

Cabot Corporation logo
Cabot CorporationCBT
$32M+3,100%
Unifirst logo
UnifirstUNF
$35.22M-6.5%
Warrior Met Coal logo
Warrior Met CoalHCC
-$91.86M-59.5%
Travel + Leisure logo
Travel + LeisureTNL
$19M-81.0%
Bioventus logo
BioventusBVS
$8.36M+141%
Dave, Inc. logo
Dave, Inc.DAVE
$82.01M+81.4%

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%

Valuation

See full
Market cap$43.78B+3.9%
Enterprise value$44.15B+3.4%
P/E40×-7.1×
P/S9.9×-0.9×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Calculated from Idexx Laboratories’s reported figures.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's free cash flow?
Idexx Laboratories (IDXX) reported free cash flow of $234.26M in Q1 2026.
How has Idexx Laboratories's free cash flow changed year-over-year?
Idexx Laboratories's free cash flow increased by 12.7% year-over-year, from $207.94M to $234.26M.
What is the long-term trend for Idexx Laboratories's free cash flow?
Over 4 years (2021 to 2025), Idexx Laboratories's free cash flow has grown at a 13.5% compound annual growth rate (CAGR), from $636M to $1.06B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.